HDL-C concentration is related to markers of absorption and of cholesterol synthesis: Study in subjects with low vs. high HDL-C.

[1]  M. Phillips,et al.  High-density lipoprotein heterogeneity and function in reverse cholesterol transport , 2010, Current opinion in lipidology.

[2]  U. Laufs,et al.  Relationship between cholesterol synthesis and intestinal absorption is associated with cardiovascular risk. , 2010, Atherosclerosis.

[3]  Christopher P Cannon,et al.  High-density lipoprotein and coronary heart disease: current and future therapies. , 2010, Journal of the American College of Cardiology.

[4]  E. Quintão,et al.  Lipid transfer proteins: past, present and perspectives. , 2010, Atherosclerosis.

[5]  Jonathan C. Cohen,et al.  Indices of cholesterol metabolism and relative responsiveness to ezetimibe and simvastatin. , 2010, The Journal of clinical endocrinology and metabolism.

[6]  B. Fagerberg,et al.  Proteomics of Apolipoproteins and Associated Proteins From Plasma High-Density Lipoproteins , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[7]  D. Noto,et al.  Plasma Non–cholesterol Sterols: A Useful Diagnostic Tool in Pediatric Hypercholesterolemia , 2010, Pediatric Research.

[8]  J. Jukema,et al.  Cholesterol absorption and synthesis markers in individuals with and without a CHD event during pravastatin therapy: insights from the PROSPER trial , 2010, Journal of Lipid Research.

[9]  J. Kastelein,et al.  Reduced fecal sterol excretion in subjects with familial hypoalphalipoproteinemia. , 2009, Atherosclerosis.

[10]  A. Zwinderman,et al.  Paraoxonase variants relate to 10-year risk in coronary artery disease: impact of a high-density lipoprotein-bound antioxidant in secondary prevention. , 2009, Journal of the American College of Cardiology.

[11]  M. Pencina,et al.  Alterations in cholesterol absorption/synthesis markers characterize Framingham Offspring Study participants with CHD[S] , 2009, Journal of Lipid Research.

[12]  U. Laufs,et al.  Alterations in cholesterol homeostasis are associated with coronary heart disease in patients with aortic stenosis , 2009, Coronary artery disease.

[13]  G. Watts,et al.  Plasma markers of cholesterol homeostasis in metabolic syndrome subjects with or without type-2 diabetes. , 2009, Diabetes research and clinical practice.

[14]  J. Oram,et al.  The cell cholesterol exporter ABCA1 as a protector from cardiovascular disease and diabetes. , 2009, Biochimica et biophysica acta.

[15]  D. Sviridov,et al.  High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus , 2009, Circulation.

[16]  A. Scanu,et al.  HDL: bridging past and present with a look at the future , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  G. Tomkin.  The intestine as a regulator of cholesterol homeostasis in diabetes. , 2008, Atherosclerosis. Supplements.

[18]  H. Gylling,et al.  The validity of serum squalene and non-cholesterol sterols as surrogate markers of cholesterol synthesis and absorption in type 2 diabetes. , 2008, Atherosclerosis.

[19]  L. Jia,et al.  Niemann-Pick C1-Like 1 Is Required for an LXR Agonist to Raise Plasma HDL Cholesterol in Mice , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[20]  H. Gylling,et al.  The distribution of squalene and non-cholesterol sterols in lipoproteins in type 2 diabetes. , 2007, Atherosclerosis.

[21]  E. Ros,et al.  Increased intestinal cholesterol absorption in autosomal dominant hypercholesterolemia and no mutations in the low-density lipoprotein receptor or apolipoprotein B genes. , 2007, The Journal of clinical endocrinology and metabolism.

[22]  F. Kuipers,et al.  Direct intestinal cholesterol secretion contributes significantly to total fecal neutral sterol excretion in mice. , 2007, Gastroenterology.

[23]  L. Niskanen,et al.  Markers of absorption and synthesis of cholesterol in men with type 1 diabetes , 2007, Diabetes/metabolism research and reviews.

[24]  G. Assmann,et al.  Relationship between phytosterol levels and components of the metabolic syndrome in the PROCAM study , 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[25]  James D. Johnson,et al.  β-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment , 2007, Nature Medicine.

[26]  M. Hallikainen,et al.  Postprandial behavior of plasma squalene and non-cholesterol sterols in men with varying cholesterol absorption. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[27]  S. Grundy,et al.  Metabolic syndrome and hyperglycemia: congruence and divergence. , 2006, The American journal of cardiology.

[28]  G. Federici,et al.  Simultaneous determination of plasmatic phytosterols and cholesterol precursors using gas chromatography-mass spectrometry (GC-MS) with selective ion monitoring (SIM). , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[29]  Albert K Groen,et al.  Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. , 2006, The Journal of clinical investigation.

[30]  E. Vartiainen,et al.  Changes in serum level and metabolism of cholesterol with plant stanol esters in postmenopausal women with and without coronary artery disease , 2006, Menopause.

[31]  H. Gylling,et al.  Effect of statins on noncholesterol sterol levels: implications for use of plant stanols and sterols. , 2005, The American journal of cardiology.

[32]  Ji-Young Lee,et al.  ATP-binding cassette transporter AI and its role in HDL formation , 2005, Current opinion in lipidology.

[33]  H. Isoniemi,et al.  Sterol parameters as markers of liver function in primary biliary cirrhosis before and after liver transplantation , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[34]  Charles C Schwartz,et al.  Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.M300511-JLR200 , 2004, Journal of Lipid Research.

[35]  H. Gylling,et al.  Cholesterol metabolism in type 1 diabetes. , 2004, Diabetes.

[36]  J. Levy,et al.  Use and abuse of HOMA modeling. , 2004, Diabetes care.

[37]  E. D. de Faria,et al.  Antioxidative Activity of HDL Particle Subspecies Is Impaired in Hyperalphalipoproteinemia: Relevance of Enzymatic and Physicochemical Properties , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[38]  H. Gylling,et al.  Synthesis and absorption markers of cholesterol in serum and lipoproteins during a large dose of statin treatment , 2003, European journal of clinical investigation.

[39]  H. Gylling,et al.  Cholesterol synthesis and absorption in coronary patients with lipid triad and isolated high LDL cholesterol in a 4S subgroup. , 2003, Atherosclerosis.

[40]  F. Kuipers,et al.  Relation between hepatic expression of ATP-binding cassette transporters G5 and G8 and biliary cholesterol secretion in mice. , 2003, Journal of hepatology.

[41]  M. Siimes,et al.  Squalene and Noncholesterol Sterols in Serum and Lipoproteins of Children with and without Familial Hypercholesterolemia , 2003, Pediatric Research.

[42]  Jukka T Salonen,et al.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.

[43]  H. Gylling,et al.  Inheritance of cholesterol metabolism of probands with high or low cholesterol absorption DOI 10.1194/jlr.M200155-JLR200 , 2002, Journal of Lipid Research.

[44]  H. Gylling,et al.  Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetics. , 2002, Obesity research.

[45]  F. Kuipers,et al.  Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL , 2001 .

[46]  W. Fung-Leung,et al.  ATP-binding cassette transporter A1 (ABCA1) affects total body sterol metabolism. , 2001, Gastroenterology.

[47]  H. Gylling,et al.  Cholesterol absorption efficiency and sterol metabolism in obesity. , 2000, Atherosclerosis.

[48]  D. Ruggio,et al.  Precise quantitative determination of phytosterols, stanols, and cholesterol metabolites in human serum by capillary gas-liquid chromatography. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[49]  H. Gylling,et al.  Cholesterol Absorption, Synthesis, and LDL Metabolism in NIDDM , 1997, Diabetes Care.

[50]  J. Frohlich,et al.  Cholesterol esterification rate in plasma depleted of very low and low density lipoproteins is controlled by the proportion of HDL2 and HDL3 subclasses: study in hypertensive and normal middle-aged and septuagenarian men. , 1992, Journal of lipid research.

[51]  H. Gylling,et al.  Non-cholesterol sterols, absorption and synthesis of cholesterol and apolipoprotein A-I kinetics in a Finnish lecithin-cholesterol acyltransferase deficient family. , 1992, Atherosclerosis.

[52]  A. Tall,et al.  Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[53]  N. O'Meara,et al.  Cholesterol Metabolism in Alloxan-Induced Diabetic Rabbits , 1990, Diabetes.

[54]  L. Castilho,et al.  Origin of intestinal lymph cholesterol in rats: contribution from luminal absorption, mucosal synthesis and filtration from plasma. , 1989, Lymphology.

[55]  T. Miettinen,et al.  Cholesterol absorption: regulation of cholesterol synthesis and elimination and within-population variations of serum cholesterol levels. , 1989, The American journal of clinical nutrition.

[56]  R. Norum,et al.  Effect of blood high density lipoprotein cholesterol concentration on fecal steroid excretion in humans. , 1983, Life sciences.

[57]  T. Miettinen,et al.  Gas-liquid chromatographic determination of fecal neutral sterols using a capillary column. , 1982, Clinica chimica acta; international journal of clinical chemistry.

[58]  A. Sipahi,et al.  Origin of cholesterol transported in intestinal lymph: studies in patients with filarial chyluria. , 1979, Journal of lipid research.

[59]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[60]  E. H. Ahrens,et al.  Regulation of cholesterol metabolism in the dog. II. Effects of complete bile diversion and of cholesterol feeding on pool sizes of tissue cholesterol measured at autopsy. , 1973, The Journal of clinical investigation.

[61]  E. H. Ahrens,et al.  Regulation of cholesterol metabolism in the dog. I. Effects of complete bile diversion and of cholesterol feeding on absorption, synthesis, accumulation, and excretion rates measured during life. , 1973, The Journal of clinical investigation.

[62]  S. Grundy,et al.  Effects of dietary cholesterol on the regulation of total body cholesterol in man. , 1971, Journal of lipid research.

[63]  E. Schaefer,et al.  Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway. , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[64]  E. Schaefer,et al.  patient-oriented and epidemiological research Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers , 2009 .

[65]  R. Hyšpler,et al.  Relation of cholesterol metabolism and non-cholesterol sterols to insulin resistance. , 2007, Physiological research.

[66]  H. Gylling,et al.  Low synthesis and high absorption of cholesterol characterize type 1 diabetes. , 2004, Diabetes care.

[67]  L. Lagrost,et al.  Determination of the mass concentration and the activity of the plasma cholesteryl ester transfer protein (CETP). , 1998, Methods in molecular biology.